Used as a key intermediate in pharmaceutical synthesis, particularly in the development of biologically active compounds. Its structure supports the formation of constrained ring systems that enhance selectivity and metabolic stability in drug candidates. Commonly employed in Suzuki-Miyaura cross-coupling reactions, it enables the efficient construction of complex organic molecules, especially in the discovery of central nervous system agents and protease inhibitors. The tert-butoxycarbonyl (Boc) protection group allows for controlled reactivity, making it suitable for multi-step synthetic routes. Its trifluoroborate moiety offers improved stability and handling compared to boronic acids, facilitating reliable scale-up in medicinal chemistry applications.